On 17 June, the European Parliament approved new rules on New Genomic Techniques. Plants with fewer than 20 genetic modifications, NGT-1, are now treated like conventional crops. No risk assessment. No traceability. No label on the food, just on the seed bag, so farmers know and nobody else has to [1]. CRISPR : Imagine having a tool that could rewrite the blueprint of life with incredible precision. Why this vote on crops gene editing happened Environmental sustainability NGT-1 crops are pitched as crops that need less water, fewer pesticides and less fertilizer, exactly the inputs Europe is trying to cut under its own climate targets. Faster drought and disease resistance means fewer crop failures as growing seasons get less predictable. That is the case the European Commission has been building since 2021, when its own study tied NGTs to the European Green Deal.[2] Social sustainability EU tillage and grain farmers have spent years absorbing rising input costs, shrinking direct payments and a shrinking list of approved plant protection products. The pitch was that faster breeding gets resilient varieties to those farmers sooner, instead of leaving them to absorb the next bad season on tools from the 1990s. Economic sustainability The US, China and South America have run more permissive gene-editing rules for years. The EU's own approval process has been slower than all three. Eight years of legislative back and forth on this file is itself a competitiveness cost, and several of the agricultural groups that pushed loudest for the vote said so directly. All three of those are real pressures, and none of them required touching the patent question. That is where this gets interesting.[3] The wrong argument everyone is having Everyone is arguing about whether that is safe. That is the wrong argument. The right one starts with a question every student has asked at least once and nobody ever gets a real answer to: who decided that was the pass mark? The scientific debate Brussels used to justify the vote Detlef Weigel at Max Planck says it plainly. If a CRISPR-edited plant has no foreign DNA and only changes that could occur through natural mutation, there is no scientific reason to regulate it like a transgenic GMO.[1] Detlef Weigelon Michael Antoniou at King's College London says the opposite. He has data showing the CRISPR editing process itself causes large-scale, unintended changes to the plant's DNA, sometimes in the hundreds or thousands of sites. A mutation count of 20 does not see that. It was never designed to.[1] Dr. Michael Antoniou Two scientists. Two credible positions. And a pass mark of 20, sitting between them, looking like it settled something. Every exam has a pass mark. Nobody asks why 50% and not 45%. The number just sits there, doing the work of sounding precise so nobody has to argue about what precise would actually require. Twenty genetic modifications is Brussels' pass mark. Below it, your crop graduates to “conventional.” Above it, back to the regulatory remedial class. Ask Weigel and Antoniou to grade the same exam and you would get two different report cards. The EU handed out one anyway. The question nobody in this debate is naming The environmental, social and economic case got Brussels to drop traceability and labelling. None of it required Brussels to touch preventability. NGT crops can still be patented. Critics have already flagged that this favors Bayer, Syngenta and Corteva over the SMEs and farmer cooperatives that cannot absorb that cost.[4] Here is the question worth sitting with. Faster climate adaptation, food security and competitiveness all require faster breeding tools. Do any of them require a patent regime? If the urgency was real and the patent question was separate, why did both pass in the same vote, defended by the same speech? Funny, how that works out for the three companies large enough to file at scale, and considerably less funny for the cooperative that is not. So the real question Brussels answered was not “is this safe” or even “can we move fast enough on climate, food security and competitiveness.” It was “who owns the genome once we move fast.” And the pass mark of 20 modifications never had anything to say about that. It was never built to. The pattern we see on boards That is a governance failure dressed up as a scientific debate. We see this pattern constantly. A board approves a strategy built on a number that sounds rigorous, 20 modifications, 73% circularity, net zero by 2040, and nobody in the room asks the exam question. Why this pass mark. Who set it. What does it conveniently fail to measure. If you wrote a sustainability strategy for your board this year, go find your version of 20 modifications. Every strategy has one. The threshold everyone nodded at because it had a number attached, not because anyone checked what the number was actually grading. How this gets done right? Grade the outcome, not the pass mark Require genomic profiling pre-market, the kind Antoniou is asking for, and make the result public. That gives you Weigel's precision argument and Antoniou's safety argument in the same framework, instead of a single number standing in for an exam nobody actually sat [1]. Separate the urgency case from the ownership case Fast-track approval for traits with genuine environmental, food security or competitiveness value: drought tolerance, pest resistance, reduced input use. Do not fast-track patent rights in the same vote, on the strength of the same urgency speech. If presentability was the actual industrial policy goal, say so and debate it as industrial policy. It deserves better than riding in on an environmental, social and economic argument that 18 EU states approved in April with limited public scrutiny [1]. Price the asymmetry A small seed cooperative and Bayer do not face the same patent cost, even when both are solving the same climate problem. One of them can afford to sit the exam twice. If your regulation does not account for that, you have not accelerated climate adaptation. You have consolidated a market and handed it a diploma. Where this leaves boards This is what we do for boards before the vote, not after the headline. We find the pass mark hiding in the strategy and ask who set it, and what it was quietly built to avoid measuring. Then we price what that costs you. If your sustainability or innovation strategy has a number like this sitting inside it, you already know the one we are talking about. Start there. [1] https://www.dw.com/en/crispr-gene-editing-for-crops-precision-tool-or-new-risk/a-77579053 [2] https://food.ec.europa.eu/plants/genetically-modified-organisms/new-developments-biotechnology/ec-study-new-genomic-techniques_en [3] https://www.helsinkitimes.fi/world-int/28952-eu-backs-new-gene-edited-crop-rules-despite-opposition.html [4] https://www.courrierinternational.com/explainer/ngt-que-va-changer-la-loi-sur-les-nouveaux-ogm-en-europe_245392

Corporate Social Responsibility (CSR) is no longer a side note in business. It’s a critical driver of success. But how do you create CSR strategies that truly make an impact online? How do you ensure your efforts resonate, engage, and deliver measurable results? The answer lies in mastering the art of online CSR strategies that are bold, authentic, and actionable. You might be wondering: Isn’t CSR just about doing good? Yes, but it’s also about doing well by doing good. It’s about transforming sustainability challenges into profit opportunities. If you’re ready to stop playing catch-up and start leading, this post is your blueprint. Why Online CSR Strategies Are Non-Negotiable Today The digital world is where your audience lives, breathes, and interacts. Ignoring this space means missing out on massive opportunities to amplify your CSR impact. But it’s not just about presence; it’s about purposeful presence. Think about it. How many companies post CSR reports once a year and call it a day? That’s not enough. Your CSR efforts must be visible, transparent, and engaging online. This is where trust is built and reputations are made or broken. Online CSR strategies allow you to: Reach a global audience instantly Engage stakeholders in real-time conversations Showcase measurable impact with data and stories Build a community around your values If you’re in sectors like pharmaceutical, chemical, agro-food, textile, cosmetics, materials, or energy, your CSR footprint matters more than ever. These industries face intense scrutiny. Your online CSR strategy can be your shield and your sword. Crafting Online CSR Strategies That Deliver Real Results Creating impactful CSR strategies online is not guesswork. It requires precision, planning, and passion. Here’s how to get it right: 1. Define Clear, Measurable Goals What does success look like for your CSR efforts? Is it reducing carbon emissions by 20%? Supporting 1,000 local farmers? Increasing employee volunteer hours? Set specific, measurable, achievable, relevant, and time-bound (SMART) goals. 2. Know Your Audience Inside Out Who are you talking to? Investors? Customers? Local communities? Each group cares about different aspects of CSR. Tailor your messaging and channels accordingly. Use social media analytics, surveys, and feedback loops to refine your approach. 3. Leverage Storytelling and Transparency Numbers tell part of the story, but stories move hearts and minds. Share real-life examples of how your CSR initiatives change lives or protect the environment. Be transparent about challenges and setbacks. Authenticity builds trust. 4. Use Digital Tools to Amplify Impact From interactive dashboards to virtual events, digital tools can make your CSR efforts more engaging. Consider: Live-streaming community projects Creating infographics and videos Hosting webinars on sustainability topics 5. Collaborate and Co-Create Partner with NGOs, local governments, and even competitors to scale your impact. Online platforms make collaboration easier than ever. Joint campaigns can multiply reach and credibility. 6. Monitor, Measure, and Adapt Use KPIs and analytics to track progress. What’s working? What’s not? Be ready to pivot. Continuous improvement is the hallmark of successful CSR. Remember, online csr strategy development is a dynamic process. It’s not a one-time setup but an ongoing journey. The Role of Technology in Online CSR Strategies Technology is the engine driving modern CSR. It’s not just about automation or data collection. It’s about creating immersive, interactive experiences that connect people to your mission. Imagine virtual reality tours of your sustainable farms or AI-powered platforms that match employee skills with volunteer opportunities. These innovations make CSR tangible and exciting. Moreover, blockchain technology can enhance transparency by providing immutable records of your CSR activities. This builds confidence among stakeholders who demand accountability. Don’t underestimate the power of mobile apps either. They can engage employees and customers alike, turning CSR into a daily habit rather than a quarterly report. Overcoming Common Challenges in Online CSR Strategy Development Let’s be honest. Developing impactful online CSR strategies is not without hurdles. You might face: Resource constraints: Limited budgets or staff can stall initiatives. Data overload: Too much information without clear insights. Stakeholder skepticism: Doubts about sincerity or impact. Regulatory complexities: Navigating compliance in multiple regions. How do you tackle these? Start by prioritizing initiatives that align with your core business and values. Use data analytics tools to filter and focus on key metrics. Communicate openly to build trust and invite feedback. And stay informed about legal requirements to avoid pitfalls. Remember, every challenge is an opportunity to innovate and differentiate. Taking Your Online CSR Strategy to the Next Level You’ve laid the groundwork. You’ve engaged your audience. Now, how do you scale and sustain your impact? Integrate CSR into your brand DNA: Make it part of your company culture and decision-making. Empower employees as CSR ambassadors: Encourage them to share their stories and ideas. Invest in continuous learning: Stay ahead of trends and best practices. Celebrate and publicize successes: Recognition fuels momentum. By doing this, you don’t just comply with expectations—you exceed them. You turn CSR from a cost center into a competitive advantage that drives growth and loyalty. If you want to dive deeper into effective online csr strategy development, explore resources and expert guidance tailored to your industry and goals. Creating impactful online CSR strategies is not optional anymore. It’s urgent. It’s essential. It’s your pathway to a sustainable, profitable future. Are you ready to lead the change?

We were not looking for this. We were doing research on something else entirely when I landed on an article by the Association for Asian Studies titled "Teaching about the Comfort Women during World War II and the Use of Personal Stories of the Victims." The article describes the comfort women system as the largest case of government-sponsored human trafficking and sexual slavery in modern history, created and controlled by the Imperial Japanese government between 1932 and 1945.[1] Then I read Yong Soo Lee's testimony. Taken from her home in Korea at sixteen. Transported across three countries in cargo ships. Forced to serve soldiers daily. Warned her family would be killed if she spoke. Then Jan O'Herne. Dutch, twenty-one years old, selected from a prison camp lineup by officers who walked the row and pointed. Returned three months later with a threat sewn into her silence. Then I stopped reading and started thinking about the pattern. Korean comfort women who survived and where in Lamang (1945) Wartime rape as a governance failure The scale of a crime that never stopped 200,000 women. That is the documented minimum for the Japanese "comfort women" system alone. They were forced into sexual slavery by the Imperial Japanese Armed Forces across occupied territories before and during World War II. The word "comfort" was chosen deliberately. Someone in a leadership position chose that word.[2] That tells you everything about how power relates to this crime. Rape during wartime is an act as old as war itself. It was not documented as a strategic military practice until World War I. After World War I, these crimes were never prosecuted, which further encouraged the use of mass rape as a strategic military operation in subsequent conflicts.[3] It did not stop. Between 250,000 and 500,000 women were raped in just three months in Rwanda in 1994. More than 200,000 are estimated to have been raped in Sierra Leone during the 1990s. Hundreds of thousands of women were violated in the DRC's 20-year war.[4] In Bosnia, systematic rape was used as part of a strategy of ethnic cleansing. Women were raped specifically so they would give birth to a Serbian baby.[5] Rape as policy This is not violence that happens alongside war. One of the most significant shifts in current thinking is the recognition that rape in wartime is not a by-product of war, but often a planned and targeted policy.[6] It is a governance decision. When you plan it, resource it, and command it through a military chain of authority, it is policy. And policy reflects the values of those who set it. The accountability that never came Now ask the harder question. What does it say about the leaders of these countries when the crime is documented, the perpetrators are known, and accountability still fails to arrive? The rapes admitted and listed as war crimes were dismissed during the Nuremberg trials, probably because they were also practiced by Allied armies.[7] U.S. servicemen committed an estimated 3,500 rapes in France between June 1944 and the end of the war. These were the liberators. A local saying from Normandy survived because it is precise: "With the Germans, the men had to camouflage themselves. With the Americans, we had to hide the women."[8] The command structure knew. Eisenhower received a formal complaint from the Free French Forces. He issued orders. The rapes continued. Of the 152 troops charged with rape by the Army in France, 139 were African American. Of the 29 soldiers executed for rape, 25 were African American. In a country where Black soldiers were systematically excluded from combat units, leadership roles, and military honors, they were suddenly overrepresented in rape convictions. The crime was not being prosecuted. Specific bodies were being sacrificed to protect the narrative of liberation. That is a governance decision. Colonialism used the same weapon In the Belgian Congo, rape, sexual exploitation and torture of native women were used as punishment, extortion, and a display of colonial power. Brutality and intimacy were basic to colonialism itself.[9] Belgian colonial officials and their sentries employed rape and sexual torture on a massive scale during the rubber regime of King Leopold II. Contemporary international discourse on conflict-related sexual violence in eastern DRC is marked by its complete omission of this history.[10] The omission is structural. When a country's leaders refuse accountability for this crime, they are not protecting soldiers but the architecture that made the crime possible: the chain of command, the ideology, the institutional silence. Who decides which suffering counts Japan's conservative political establishment spent decades insisting comfort women were voluntary. Controversies over comfort women statues and Japanese history textbooks continue. Conservatives insist that comfort women were voluntary prostitutes. The ongoing efforts to secure justice underscore the unending battle against stigma toward survivors.[11] I call that an active governance of whose suffering counts. Leadership boards that are 90% male and homogeneous do not just miss market risk. They miss which crimes get named, which victims get compensated, and which atrocities get written out of the textbooks their children read. Boards do not fail on diversity metrics. They fail on the decisions that homogeneity made invisible. The question every board member, every policy maker, and every government minister should be asked is not "did you commit the crime?" The question is: who decided it did not count? Because someone always decides that. And that someone is always in a leadership position. The oldest materiality assessment there is In CSR, we call it materiality assessment. You decide which risks are significant enough to report, to manage, to price. The comfort women were a materiality decision. The rapes in Normandy were a materiality decision. Colonial sexual violence was a materiality decision. Every time a leadership body decides that a category of harm does not count, it is performing the same calculation that modern boards perform when they exclude social risk from their balance sheets. The mechanism is identical. Only the language has changed. At Trianon, we have argued for years that separating the Ministry of Ecology from the Ministry of Foreign Affairs is itself a governance failure. Environmental destruction does not stop at borders. Sexual violence in conflict zones is inseparable from the collapse of ecosystems, the competition for land and water, and the economic desperation that armed groups exploit. A ministry that manages climate and a ministry that manages conflict should not be producing separate reports, separate budgets, and separate accountability frameworks for what is, structurally, the same problem. The women in this article were not harmed by isolated actors. They were harmed by systems. Governing systems requires seeing them whole. Documented reports of sexual violence exist in several active conflicts today. Ukraine, Gaza, Sudan, the Democratic Republic of the Congo, Myanmar, Syria, Somalia, South Sudan, Haiti, and the Central African Republic are all covered in the UN Secretary-General's most recent annual report on conflict-related sexual violence. The UN recorded nearly 10,000 cases of conflict-related sexual violence worldwide in 2025 alone, more than double the previous year's figure. In Sudan, two-thirds of women frontline responders reported a significant increase in sexual violence in 2025, with half reporting further escalation into 2026. We have not included any of them here. Not because the evidence is absent, but because all of these conflicts are active, politically contested at every level of documentation, and subject to ongoing legal proceedings. Writing about them in this format, without the investigative depth they require, would reduce living women to rhetorical ammunition. The historical cases in this article are documented, adjudicated, and in most instances officially acknowledged. They are not less serious for being past. They are simply less likely to be weaponized by readers looking for confirmation of a geopolitical position rather than an honest reckoning with how power operates. That distinction matters to me. [1] https://www.asianstudies.org/publications/eaa/archives/teaching-about-the-comfort-women-during-world-war-ii-and-the-use-of-personal-stories-of-the-victims/ [2] https://en.wikipedia.org/wiki/Comfort_women [3] https://www.sciencedirect.com/science/article/abs/pii/S0277539509000843 [4] https://www.ibtimes.co.uk/mass-rape-weapon-war-bosnia-verdict-warning-leaders-who-unbolt-heart-darkness-1551989 [5] https://www.msf.org/rape-weapon-war [6] https://link.springer.com/article/10.1007/s10691-009-9118-5 [7] https://ehne.fr/en/node/12512/printable/print [8] https://en.wikipedia.org/wiki/Rape_during_the_liberation_of_France [9] https://blogs.lse.ac.uk/africaatlse/2018/07/18/when-archives-speak-back-sexual-violence-in-the-congo-free-state/ [10] https://www.researchgate.net/publication/308126691_Sexual_Violence_in_the_Congo_Free_State_Archival_Traces_and_Present_Reconfigurations [11] https://humanwrites.umn.edu/nanjings-women-sudans-survivors-ending-rape-weapon-war

Chernobyl disaster The reactor exploded because the governance structure made telling the truth more dangerous than running the reactor. Two engineers flagged the test as unsafe. They were dismissed. The reactor ran anyway. Your board is doing the same thing with AI. Not because you are reckless. Because no one has asked the four questions that matter: What is the environmental liability of your AI footprint? Has anyone calculated it? Who has the technical authority to stop an AI decision heading in the wrong direction? What are your agents authorized to do right now, without human review? What happens when one of them is wrong? The EU AI Act deadline is August 2, 2026. Personal liability for board members. €35 million in fines. 97 days from today. The board that approved the April 25 test is not around to answer for it. The board approving your AI strategy today will be.

How Dr. Audrey-Flore Ngomsik is proving that sustainability can be profitable. An article written by Women who build Africa to highlight Dr Ngomsik mission & vision for Africa. Trianon Scientific communication

International Women’s Day focus: The patient was never me. But it might be you pubished in the Bulletin.be on March 8th, 2026

We spent two years as external consultants watching companies hire managers and directors. They paid us to improve their processes. What we saw was a masterclass in how bias disguises itself as professional judgment. Same credentials on paper. Wildly different outcomes in practice. Here’s what nobody wants to admit. Names have been changed to protect confidentiality, but the patterns are real. The First Pattern: Ethnicity Naomi and Corinne interviewed for the same director role. Same MBA from INSEAD. Same 15 years in finance. Same track record. Corinne walked in. Questions on strategic vision, risk management, industry network. Someone mentioned Verbier. Ten minutes bonding over ski resorts. The conversation flowed. Two weeks later, offer. Picture from unsplash.com Naomi walked in. Different questions appeared. “How do you handle conflict?” “Do you think you’ll fit with our culture?” “Can you work with strong personalities?” Translation: Can you deal with being the only Black woman in the room without making us uncomfortable? She gave the same answers Corinne gave. Cited research. Showed regulatory foresight expertise. No one mentioned Verbier. No one bonded. Three weeks later, email. “We’ve decided to go with someone who’s a better cultural fit.” Here’s where it gets interesting. The job posting said they valued “diverse perspectives” and “challenging the status quo.” Corinne’s innovation answer: “We should look at what our competitors are doing and identify best practices.” Naomi’s innovation answer: “Your competitors are copying each other. The regulatory landscape is shifting faster than your industry is adapting. Here’s where the gaps are.” The role’s stated priority: “Preparing the organization for regulatory changes in sustainability.” Corinne’s experience: Traditional finance. Strong on quarterly reporting. Naomi’s experience: Led three companies through major regulatory transitions. Has relationships with policymakers. Knows what’s coming before it hits the news. Guess who they called a “culture fit”? Picture generated by nano banana (AI) They said they wanted fresh thinking. Corinne suggested what they’re already doing. Naomi suggested what they’re not ready to hear. They hired Corinne. Six months later, they got blindsided by exactly the regulatory changes Naomi had flagged. What does “culture fit” actually mean when the person who fits your culture can’t see the risks the outlier spotted immediately? The Second Pattern: Ethnicity Meets Gender Same type of organization. Different director role. Claudia and Pierre. Same credentials. Same MBA, same experience, same track record. Pierre mentioned golf. Three hiring managers play golf. Ten minutes talking courses. When he spoke, they leaned in. Bold suggestion? “Strategic thinking.” One week later, offer. Picture from unsplash.com Claudia got the same questions as Noami’s before. Conflict handling. Culture fit. We watched them glance at each other. Silent communication excluding her. Three weeks later, same email. “Better cultural fit.” Picture generated by Freepik (AI) For every 100 men promoted to management, only 58 Black women get the same shot (1). Black women account for 1.4% of C-suite executives. White men hold 68% (1). When there’s only one diverse candidate in the finalist pool, they have statistically zero chance of being hired (1). The hiring committee congratulated itself on interviewing a diverse slate. What they gave Naomi was extra hoops that don’t exist for Pierre. Then they called it merit. The Third Pattern: Gender Alone Different organization. Manager position. Corinne and Pierre. Same credentials. Same interview questions. Jean spoke with confidence. They leaned in. Corinne spoke with the same confidence. We watched them shift in their seats. Jean made a bold suggestion. “Strategic thinking.” Corinne made the same suggestion. “Aggressive.” Someone asked Corinne: “This role requires significant travel. How will you manage that?” Jean never got that question. Two weeks later, email. “You’re talented, but we’re looking for someone with more executive presence.” The double blind became clear. They wanted “strong leadership.” Jean was direct. “Decisive.” Corinne was direct. “Difficult.” They valued “collaborative approach.” Jean built consensus. “Natural leader.” Corinne built consensus. “Lacks authority.” Identical CVs receive different ratings based on gender. Male candidates rated as more competent and hireable (2). A 2025 meta-analysis of 243,202 job applications confirmed systematic discrimination against women in male-dominated fields (and also confirmed the ethnicity bias) (3). Same words. Different reactions. Jean’s confidence was “executive presence.” Corinne’s confidence was “not quite right for the culture.” Picture from unsplash.com What “Culture Fit” Actually Costs We watched this pattern repeat for two years. “Culture fit” is code for comfort. Research from Northwestern’s Kellogg School found that when interviewers said they “clicked” with a candidate, they meant similar background. Same sports, same schools, same vacation spots (4). Then they dressed it up as professional judgment. Research shows that non white women believe executive presence is defined by conforming to white male standards (5), with 56% of non white people reporting they're held to higher standards than white colleagues in demonstrating executive presence (6). Women receive less quality performance feedback than men. Evaluations focus on personality traits instead of specific accomplishments (7). The “think manager, think male” phenomenon means masculine traits are associated with leadership more than feminine traits (7). These aren’t bad people making these decisions. They’re good people operating in a system designed to make bias look like merit. The Real Cost Every hiring committee we observed claimed they wanted innovation. Fresh perspectives. Someone who could help them anticipate change. Then they hired the person who reinforced what they already thought. Naomi told them where the regulatory risks were. They hired Corinne. Six months later, blindsided. Corinne gave them the same strategic recommendation as Pierre. They hired Pierre. Called him visionary. The candidates who delivered what the committees said they wanted got rejected for not fitting the culture. The candidates who reflected the existing culture back got hired. Then the organizations wondered why they kept making the same decisions. Missing the same risks. Getting caught off guard by changes they claimed they wanted to anticipate. Here’s what that pattern recognition costs them. When you reject the outlier who spots the risks comfortable insiders never see, you’re not excluding diversity. You’re excluding your early warning system. The invisible work isn’t just the extra prep Naomi and Corinne did before interviews. It’s knowing they’ll do it again at the next role. And the next one. And the next one. It’s watching less qualified candidates walk in and get assumed competent while you prove yourself despite identical credentials. It’s being told you’re “talented” but not quite right while watching someone with your exact background get called “executive material.” Why This Matters We went into this work expecting to see bias. We’ve read the research. We know the data. What surprised me was how invisible it was to the people doing it. No one in these rooms thought they were discriminating. They thought they were assessing culture fit. They thought they were evaluating executive presence. They thought they were making objective decisions about who would be best for the role. They were wrong. But the system is designed to make that wrongness look like rightness. After two years of watching this play out, here’s what we know. The game is rigged to look fair. Organizations will keep hiring comfort and calling it competence until they’re willing to examine what “culture fit” actually means in practice. They’ll keep missing the perspectives they claim to want. They’ll keep getting blindsided by risks they could have anticipated. They’ll keep congratulating themselves on their commitment to diversity while rejecting the diverse candidates who actually show up. What does it cost to hire someone who makes you comfortable instead of someone who makes you think? Ask the companies that got blindsided by the exact risks their rejected candidates flagged. They’re still calling it merit. Why We Can Help Fix This Dr Audrey-Flore Ngomsik, our co-founder, is one of statistical anomalies these hiring committees reject. Black woman. Physical & Analytical Chemistry PhD. Brussels Climate Committee VP. Multi board director. We got into these rooms by asking questions other people were afraid to ask. Then we built a methodology that turns uncomfortable truths into profit increases. For two years, we watched companies pay us to observe their hiring processes while systematically rejecting candidates who looked like Dr Ngomsik. Candidates with better qualifications. Candidates who spotted risks the “culture fits” missed. Those same companies now wonder why they keep getting blindsided by regulatory changes, market shifts, and systemic risks. Here’s what we learned: The pattern recognition that makes someone “not quite right for the culture” is exactly what spots the problems comfortable consensus misses. We work with organizations that are ready to examine what “culture fit” actually costs them. Not in moral terms. In economic terms. Because when you hire comfort over competence, you don’t just lose diverse candidates. You lose your early warning system. Trianon Scientific Communication , has helped companies increase profits by 60-80% by redesigning strategies around economic reality instead of comfortable assumptions. We start with the questions your organization has been avoiding. Then we build frameworks that work. Not every company is ready for that conversation. But the ones that are don’t stay blind to risks their competitors keep missing. If you want to examine what your hiring patterns are actually costing you, we answer provocative questions with data, not hope. (1) Lean In & McKinsey (2020). The State of Black Women in Corporate America . (2) Inside Higher Ed (2019). New study finds discrimination against women and racial minorities in hiring in the sciences . (3) Park, S.Y. & Oh, E. (2025). Getting a Foot in the Door: A Meta-Analysis of U.S. Audit Studies of Gender Bias in Hiring. Sociological Science. (4) Rivera, L. (2022). Stop Hiring for "Cultural Fit." Kellogg Insight. (5) Executive Leadership Council (2021). "Creating Standards of Leadership and Professionalism Rooted in Blackness." ELC Magazine, Winter 2021. (6) Hewlett, S.A. (2014). "Cracking the Code That Stalls People of Color." Harvard Business Review, March-April 2014 issue. (7) Catalyst (2024). Black women still face a glass cliff, but fixing workplace systems can change that.

Who Decided This Was Safe?

Every year, world leaders gather for something called COP. If you’ve heard the term but never had the patience to decode it, here’s the simple version: COP stands for " Conference of the Parties ", which sounds like the world's most boring party invitation, and honestly, it often is.[1] It is the global meeting where countries negotiate the rules that will shape your business environment for the next decade. It’s where governments decide how fast the world must cut emissions, what industries must change, and how much money flows into climate action. Think of it as the annual “board meeting” for the planet, except the decisions made there cascade into your energy bills, supply-chain requirements, investor expectations, and customer behaviour. Annual board meeting of the planet The first COP happened in Berlin in 1995. We're now at COP30, which tells you either that climate change is really complicated, or that international diplomacy moves at glacial speed. Here's the delicious irony nobody discusses enough:   Thousands of delegates travel to these conferences, often held in touristy spots, to talk about cutting carbon emissions. At COP30 in Belem, some fancy planes touched down, including an A330-200 from China, an A330-200 from France, an A340-300 from Qatar, and an A350-900 from Germany.[2] COP 28 seen with irony by Verino (in French) The carbon footprint of just one of these COP meetings? It's pretty big, which makes you think maybe Zoom calls were made for this kind of thing. But dismissing COPs as hypocrisy theatre misses something important: they actually change laws. And laws change business. Over the past decade, while we were all watching these conferences with varying degrees of scepticism, something shifted. COP decisions stopped being theoretical and started showing up as line items on P&L statements. Some companies figured out how to profit from this. Others are still treating sustainability as a PR department problem. This is the story of what actually happened when climate diplomacy met quarterly reporting. Why these last 10 years matter: The Paris turning point Paris agreement signatories (2015) We're focusing on 2015-2025 for a specific reason : this marks the decade since the Paris Agreement. For twenty-nine years (COPs 1-20), most people treated COP like distant diplomacy. Climate conferences were mostly about developed countries making promises they didn't keep. Nice speeches. Broad promises. Nothing a business owner needed to lose sleep over. Remember Kyoto in 1997? Ambitious targets, terrible compliance, and the world's largest emitter (the United States) never ratified it. But then something changed. The Paris Agreement is the first legally-binding global treaty on climate change, requiring countries to keep global temperature rise 'well below' 2°C, ideally below 1.5°C, above pre-industrial levels.[3] The Paris Agreement did something sneaky that most of us missed at the time: it included an automatic escalation clause. The "ratchet mechanism" requires countries to submit increasingly ambitious climate plans every five years. No going backwards.[4] Think of it like your streaming subscriptions, you signed up for one price, and somehow every year there's a "necessary adjustment" you never actually agreed to. In business terms: climate rules automatically get tougher every five years. For the past decade, COP decisions stopped being theoretical and started becoming law. And once they became law, they became costs. And once they became costs, they became strategy. Here's how this played out in the real world: 2016-2018: The supply chain surprise Remember when large corporates started asking for carbon data? If you're an SME, you probably thought "this doesn't apply to us." Then your biggest client sent you a sustainability questionnaire that was longer than your annual report and required data you'd never tracked. Welcome to the trickle-down effect, except it wasn't trickling, it was cascading. Whether anyone actually used  that data or just filed it in a "sustainability responses" folder? Different question entirely. The cascade wasn't about transformation, it was about liability management dressed up as supply chain engagement. 2017-2019: When investors started caring about weird stuff By COP21, 400 investors with $24 trillion in assets had signed climate action statements.[5] Suddenly investors started prioritizing a company's environmental impact over its financial projections and growth story. In 2015, 55% of CEOs identified responsible corporate engagement on climate as critical leadership behaviour. [5] Except... from 2016-2023, the world's 60 largest banks financed fossil fuels with $6.9 trillion. Eight years post-Paris, fossil fuel financing continued "unabated" at over $1 trillion annually.[6] So were investors prioritizing environmental impact over financial projections? Or were they signing statements that looked good in their own  glossy decks while the capital kept flowing to whoever offered the best returns? That is another question. The fact is that by 2020, if you weren't talking about it, you weren't getting capital. 2019-Present: The quiet divergence Companies that moved early on this stuff? They locked in cheaper financing, found operational efficiencies, and somehow made it look easy. Everyone else is now paying catch-up premiums and wondering how the rules changed without anyone sending a memo. The reality is that Paris didn't create a compliance burden for everyone equally. It created a competitive advantage for companies that read the policy signals early and a penalty for those who didn't. Which camp you're in probably depends on whether your sustainability person reports to operations or marketing. 2. The CSRD report The EU Corporate Sustainability Reporting Directive was supposed to be the moment when sustainability measurement became scientific, comparable, and, most importantly, mandatory for almost 50,000 companies.[7] It’s like being forced to track every calorie you eat, every minute you exercise, every gram of sugar you consume... and then publish it online. If you operate in Europe, even tangentially, this was supposed to apply to you. Non-EU firms with European operations? Yeah, you too. The logic was elegant: force people to measure things, and they'll improve them. And the data backed this up, SMEs that actually measure carbon emissions cut operational costs by 20–30%.[8] Why? Because once you're tracking waste, you suddenly see all the money you've been throwing away. But here's where it gets entertaining: November 2024 : The European Parliament voted to scale back the requirements. New thresholds: companies with 1,750+ employees and €450 million revenue.[9] February 2025 : The Omnibus proposals suggested limiting it to companies with 1,000+ employees.[10] So the regulations were getting tougher, except when they weren't. Planning your sustainability budget just got a lot more interesting, or frustrating, depending on whether you'd already invested in the systems. Here's the twist nobody saw coming: the companies that had already set up measurement systems before the rollback? They're now ahead of their competitors.   Those who waited for "regulatory clarity" are scrambling to catch up with clients and investors who moved ahead of the regulations anyway. Turns out the market doesn't wait for politicians to make up their minds. The lesson : Regulations zigzag. Market expectations move in one direction. If your strategy is "let's wait and see what the regulations say," you're playing a game everyone else has already finished. 3. When pollution finally got expensive This is where the science meets your wallet. Here's a stat that shouldn't work but does: The EU Emissions Trading System managed to get manufacturing firms to reduce CO₂ emissions by 14–16% without any visible negative impacts on economic activity or employment.[11] Read that again: emissions down, jobs fine, output maintained. Carbon prices went from "essentially free" in 2007 to €73 per tonne in 2024.[12] Over 20 years, the EU ETS helped cut emissions from electricity, heat generation, and industry by 50% .[13] So what actually happened when carbon got expensive? Everyone worried companies would just move production to countries without carbon pricing. The concern was that companies would move production to countries without carbon pricing. However, as it turned out, most companies decided to invest in efficiency measures because, obviously, it was cheaper than relocation of the whole production. [11] Financial institutions began to include climate risk in their pricing .  Companies with high ESG scores now get 10% discounts on cost of capital  compared to low performers.[14] This is not an act of virtue from these firms; rather, it is banks doing calculations on which clients are more likely to face unanticipated costs. Size played a role, but not in the way you would expect. While big corporations were engaged in political battles over carbon pricing issues, small businesses were silently improving their operations and maintaining their margins.[15] So, it appears that being agile has its merits. As soon as pollution became a quantifiable expense on the Profit & Loss account, it was a controllable cost. Firms that looked at carbon pricing as an opportunity for financial optimization performed better than those that saw it as a political issue to grumble about. Furthermore, it turns out that when you make something costly, people come up with ways to use less of it. Economics 101, in relation to ​‍​‌‍​‍‌carbon. 4. When sustainability became a money maker This is the part of the story people still underestimate. Companies with strong sustainability practices earned 2.6× higher shareholder returns  from 2013-2020.[15] Products marketed as sustainable grew 2.7× faster .[17] ESG leaders made 8% higher returns  than the broader U.S. market in 2021.[14] Sustainability-focused S&P 500 companies showed 18% higher ROIs .[17] But here's the part that explains everything: 74% of CEOs called sustainability a top priority. Only 45% measured its ROI. [18] That gap between saying something matters and actually tracking whether it's working, explains the performance divergence we've been seeing. In food and agriculture : Anheuser-Busch InBev improved operating income by working with barley growers on sustainable farming. Better raw materials, less waste, higher margins. Not because they suddenly cared about the planet, because efficiency compounds.[19] In fashion and materials : Nike boosted margins by switching to lighter, cleaner materials and reducing supply chain waste.[19] Turns out "sustainable" and "cheaper to ship" often mean the same thing. In energy : Industries worldwide could save $437 billion annually by 2030  through improved energy efficiency.[20] Most won't, because they're not measuring where energy is being wasted in the first place. Companies treating sustainability as a measurable business function found cost reductions and margin improvements. Companies treating it as a compliance exercise or PR function found neither, treat it as just expenses. Which means most companies are spending money on sustainability done wrong while their competitors quietly profit from sustainability done right. The uncomfortable bit? You probably can't tell which category you're in without actually measuring it. The social side: The business impact most leaders ignore Climate policy is no longer just about CO₂. It’s about people. As it should have been from the start, it isn't just about emissions anymore, it's about not destroying people's lives while you fix the emissions. Early COPs were pure carbon talk. By COP24 in Katowice (2018), the Just Transition Declaration showed up. By COP30, it became the Belém Action Mechanism for Just Transition , an actual framework requiring proof that your decarbonization plan doesn't wreck communities.[21] COP 30 What this means in practice: Reporting expanded beyond "how much carbon did you cut?"  Now it's also: Are you creating jobs in clean industries? Are you retraining workers whose jobs disappear? Are you supporting supplier communities through transitions? Are you diversifying regional economies that depend on fossil fuels? By 2030, over 1 million new jobs  could be created in clean industries, energy efficiency, and green transport in the EU alone.[22] But you're increasingly expected to show you're creating those jobs, not just cutting emissions while communities collapse. The business reality : If your sustainability strategy harms people, three things happen: Your sustainability score tanks Your access to capital shrinks Your regulatory problems multiply Companies ahead of this are treating sustainability as risk mitigation across climate risk, supply chain risk, and  social license risk.[23] Those behind it are discovering that investors, regulators, and the public all care about the "just" part of "just transition." 6. COP30: Three things that actually matter COP30 in Belem just wrapped up. Here's what came out of it that will probably affect your business operations: COP30 won’t be about promises. It will be about proof. 1. Money gets serious Climate finance is supposed to jump from $300 billion to $1.3 trillion annually by 2035 .[24] This isn't development aid, it's about mobilizing private capital at scale. For businesses, that means new investment vehicles, supply chain financing that's tied to climate performance, and carbon credit markets with (allegedly) actual integrity standards this time. 2. Greenwashing is about to get expensive The summit emphasized regulatory scrutiny and third-party verification of climate claims.[25] Combined with the launch of the Open Coalition on Compliance Carbon Markets [26], expect mandatory audits of sustainability reports and actual consequences for making stuff up. If your sustainability report wouldn't survive an audit, the next year is going to be interesting. 3. Trees became an industry Brazil launched the $125 billion Tropical Forest Forever Facility  to pay for forest conservation starting 2026. [2] For companies in forestry, agriculture, materials, and carbon sequestration: new revenue streams. For everyone else: biodiversity reporting is about to become as standard as carbon reporting, whether you're ready or not. Expect: • strict anti-greenwashing laws • mandatory transition plans • real emissions verification (no more creative reporting) • carbon pricing in more sectors • supply-chain due diligence with teeth The era of “checkbox sustainability” is ending. The era of auditable, science-backed sustainability is here. COP outcomes usually take 6-18 months to show up as actual business requirements. Companies that wait for "regulatory clarity" consistently lose first-mover advantages to those who bet on where the policy signals are pointing. Nobody's saying you should make strategy based on what diplomats agree to at conferences. But ignoring what they agree to hasn't worked out great for the past decade either. 7. Sustainability costs money, until it saves more The IEA says transitioning to green systems costs $45 trillion  but generates $26 trillion in benefits , leaving a $19 trillion gap  that someone has to fund.[20] Spoiler: that "someone" is businesses. Through some combination of investment, carbon pricing, and stranded assets that suddenly aren't worth what they used to be. But here's the interesting part about how companies actually allocate resources: 33% of companies use sustainability explicitly to cut costs and increase efficiency. [20] 71% of C-suites say ESG is a competitive advantage. [20] Early movers gain market share and efficiency. Late movers pay compliance bills and penalties. Yet sustainability investments were less than 1% of total revenue in 2023 , while marketing budgets averaged 9.1% .[20] Let's sit with that for a second: Companies spend 9× more on telling people about value than on operational changes that could reduce waste, cut costs, eliminate supply chain risk, improve access to capital, and open new markets. This allocation decision explains a lot: Early movers invested in efficiency gains. They captured cost advantages. They got better financing terms. They gained market positioning. Late movers are now paying compliance costs and catch-up premiums, without the competitive benefits that came from moving early. The market doesn’t reward “good intentions.” It rewards companies that reduce waste, innovate materials, eliminate risk, and use sustainability as a revenue engine. Which might explain why some companies profit from sustainability while others just complain about it. This is what expert at Trianon Scientific Communication always say: " Your problem might not be sustainability per say, but the solution always is". 8. What actually works (according to the data) After watching companies across energy, materials, pharmaceuticals, food, fashion, and cosmetics navigate this decade, here are the patterns that keep showing up in successful strategies versus expensive ones: 1. Measure everything Companies that don’t measure ROI fail. Waste is invisible until you quantify it. 2. Start with operational efficiency SMEs cut 20–30% of costs with streamlined carbon accounting. 3. Use sustainability to enter new markets Investors prefer companies with credible ESG performance. Consumers reward better products. Banks give better rates. 4. Invest in technology that pays back AI for resource efficiency. Cleaner materials that reduce waste. Energy upgrades that reduce bills. Packaging innovations that increase loyalty. 5. Stop greenwashing Authenticity now has financial value. Auditors, investors, courts, and regulators agree. 9. What's probably coming next (based on pattern recognition) Looking at how COP outcomes have historically turned into business requirements, here's what the pattern suggests is coming: 2025–2026: The immediate stuff Scope 3 emissions reporting (that's your whole supply chain) will go from "nice to have" to mandatory for mid-market companies. Anti-greenwashing regulations will shift from vague principles to actual enforcement. Carbon border adjustments will start affecting international trade. Banks will integrate climate risk into lending decisions, not as a CSR tick-box but as actual credit assessment. 2027–2030: The medium-term expansion Mandatory climate transition plans won't just be for massive corporations anymore, mid-sized firms will need them too. Just-transition reporting will emerge (proving you're not destroying communities, not just proving you cut emissions). Carbon pricing will spread to sectors that currently don't pay. Supply chain due diligence laws will get enforcement mechanisms with real financial penalties attached. Post-2030: The speculative horizon AI-driven real-time emissions monitoring will probably become standard infrastructure. Biodiversity reporting might become as standard as carbon reporting. Personal carbon allowances could affect consumer behaviour in some markets. Climate litigation will transition from "unusual legal issue" to "normal cost of business." The timeline from "international agreement" to "business requirement" has consistently gotten shorter over the past decade. Companies positioning on these patterns capture first-mover advantages. Those waiting for absolute regulatory certainty consistently end up paying premiums for late adaptation. Your mileage may vary. But the trend line has been pretty consistent. 10. So what did ten years of COPs actually change? Looking back at what actually happened when climate diplomacy met quarterly earnings, three things stand out: 1. The economics flipped In 2015, sustainability was basically treated as a cost center that made executives feel good. By 2025, companies with strong sustainability practices earned 2.6× higher shareholder returns .[16] Why? Carbon pricing, supply chain requirements, and investor expectations made inefficiency more expensive than transformation. The math changed. 2. Measurement became the dividing line The performance gap between companies that measure sustainability ROI (45% of firms) and those that don't explains everything.[18] Ethical supply chains increase revenue by 20% . Sustainable operations reduce costs by 16% .[20] But only if you're measuring and optimizing. The companies profiting from climate action are measuring. The ones just paying compliance costs aren't. 3. Policy zigzags, markets don't Regulations tighten, loosen based on whoever won the last election, then tighten again. The CSRD demonstrated this perfectly. But market expectations, from investors, customers, supply chain partners, only move one direction. Companies betting their strategy on regulatory rollback keep losing to companies reading market signals. 84% of global executives believe economic growth and climate goals can go hand in hand. [24] Whether you believe it doesn't matter. Whether you position your business for it is everything. After ten years of watching this unfold, the pattern is pretty clear: Sustainability as operational discipline = increased profitability Sustainability as compliance exercise = increased costs Sustainability ignored = increased risk The companies doing well aren't the ones with impressive sustainability reports. They're the ones who integrated environmental and social metrics into actual business operations and discovered that operational efficiency protects margins. Which category is your business in? If you're not sure, that’s exactly what Trianon Scientific Communication helps companies solve, using science, strategy, and policy insight to turn sustainability into a competitive advantage. [1] https://www.cisl.cam.ac.uk/cop-climate-change-conference [2] https://en.wikipedia.org/wiki/2025_United_Nations_Climate_Change_Conference [3] https://unfccc.int/process-and-meetings/the-paris-agreement [4] https://www.carbonbrief.org/explainer-the-ratchet-mechanism-within-the-paris-climate-deal/ [5] https://unglobalcompact.org/take-action/action/cop21-business-action [6] https://www.iisd.org/publications/report/burning-billions-record-fossil-fuels-support-2022 [7] https://finance.ec.europa.eu/capital-markets-union-and-financial-markets/company-reporting-and-auditing/company-reporting/corporate-sustainability-reporting_en [8] https://www.ecohedge.com/blog/the-value-of-carbon-footprint-analysis-for-smes/ [9] https://www.esgdive.com/news/eu-parliament-votes-to-weaken-corporate-sustainability-laws-csrd-csddd/805574/ [10] https://dart.deloitte.com/USDART/home/publications/deloitte/heads-up/2025/eu-commission-omnibus-proposal-sustainability-reporting-reduction-csrd [11] https://academic.oup.com/restud/article/92/3/1625/7681739?login=false [12] https://www.environmental-finance.com/content/awards/environmental-market-rankings-2024-2025/categories/a-year-of-policy-and-politics-for-compliance-carbon-markets.html [13] https://climate.ec.europa.eu/news-other-reads/news/5-things-you-should-know-about-carbon-pricing-2025-09-05_en [14] https://www.brightest.io/esg-roi-benefits [15] https://one.oecd.org/document/CFE/SME(2024)13/FINAL/en/pdf [16] https://www.weforum.org/stories/2024/01/why-2024-is-the-year-of-the-business-case-for-sustainability-davos/ [17] https://www.businessdasher.com/business-sustainability-statistics/ [18] https://ecoskills.academy/measure-sustainability-roi-methods/ [19] https://plana.earth/academy/roi-sustainability [20] https://www.perk.com/blog/business-sustainability-statistics/ [21] https://unu.edu/ehs/article/5-expectations-cop-30-belem [22] https://commonslibrary.parliament.uk/research-briefings/cbp-10357/ [23] https://www.zevero.earth/blog/hidden-roi-of-sustainability-5-overlooked-benefits [24] https://www.business-standard.com/world-news/cop30-wrap-6-major-takeaways-from-global-climate-negotiations-2025-125112300061_1.html [25] https://www.unepfi.org/themes/climate-change/road-to-cop30-five-negotiation-outcomes-that-could-shape-global-finance/ [26] https://climate.ec.europa.eu/eu-action/climate-strategies-targets_en

When Flo Health achieved Europe's first femtech unicorn raised 200 Million Euros at a $1 billion valuation, it should have been celebrated as a breakthrough for women's health innovation.[1] Flo Health App - Image credit FLO HEALTH Instead, it exposed a troubling paradox that sustainability and CSR leaders cannot ignore: the most successful solutions for marginalized communities are consistently built and controlled by those outside these communities. As people who have spent decades helping companies integrate diversity, equity, and sustainability into profitable business strategies, we see this pattern as more than just market dynamics, it's a systemic failure that undermines the very principles of inclusive, sustainable capitalism we're working to build. The sustainability imperative: Why this matters beyond business. This isn't merely about venture capital fairness, it's about the fundamental sustainability of our economic systems. When we systematically exclude the voices and leadership of those closest to critical problems, we create solutions that are inherently incomplete and unsustainable. The pattern reveals itself across industries with startling consistency: Vlisco  has dominated the "African fabric" market for 175 years from the Netherlands, while African textile entrepreneurs struggle to access global markets, a clear example of extractive rather than regenerative business models.[2] Vlisco fabric - CREDIT Philadelphia Museum of art SheaMoisture  was built on the hair care wisdom of Black women, yet its most significant growth came after acquisition by Unilever in 2017 for an estimated $1.6 billion. Unilever acquired SheaMoisture's parent company, Sundial Brands, on November 27, 2017. This acquisition was part of Unilever's strategy to expand its portfolio in the multicultural beauty sector, targeting products for Black and ethnic minority consumers. A commercial controversy erupted after the brand released an ad that many felt inadequately represented its core customer base, black women with diverse hair textures. Critics argued that this approach seemed to dilute the brand's focus on its original demographic, and accused them of "white-washing" the product. This backlash prompted SheaMoisture to apologize and withdraw the ad, acknowledging that they failed to properly represent the community that has historically supported them. The brand emphasized its commitment to ensuring that Black women's hair journeys are recognized and valued in future campaigns. It illustrated the disconnect that can occur when outsiders control culturally specific brands, and demonstrated exactly why diversity in decision making matters for long-term economic sustainability. Shea Moisture apologizes after backlash To ad featuring caucasian women Urban Outfitters  sold over 20 product lines using the "Navajo" name and designs mimicking Navajo tribal patterns, including clothing, jewelry, underwear, and accessories. The Navajo Nation sued the retailer in 2012 for trademark infringement and violation of the Indian Arts and Crafts Act. Although the exact financial terms of the 2016 settlement remain confidential, court records reveal that Urban Outfitters sold tens of thousands of "Navajo" branded units annually (30,733 units in 2008), rising to 78,231 in 2009, and 49,182 in 2010. The Navajo Nation was also entitled to seek damages of at least $1,000 per day for each type of infringing product sold, potentially amounting to millions in damages. Following the settlement, Urban Outfitters agreed to a supply and license agreement to collaborate authentically with Navajo artisans on future products. This case highlights how large corporations have profited substantially (likely millions of dollars) from culturally specific designs without initial permission or compensation to the source community.[3] Adidas Xhosa Sneakers (South Africa) : Adidas released sneakers featuring the Xhosa word uluntu  (meaning “community”), but inaccurately described it as “human race” and failed to sell the shoes in South Africa. This misrepresentation and commercial exploitation of a cultural symbol without meaningful engagement with the community drew criticism.[4]   Fenty Beauty  stands as a notable counter-example, but its success under Rihanna's ownership makes the broader pattern even more glaring by comparison. Rihanna and Fenty beauty These examples reinforce the recurring pattern where culturally specific products or traditions are commodified by outsiders or large corporations, often sidelining the original creators or communities. They also highlight the importance of authentic collaboration, respect, and equitable benefit-sharing to avoid perpetuating harm and exclusion. They illustrate what we call "extractive innovation", where value is created by taking from communities rather than empowering them to create value themselves. The numbers don't lie Here's how investment capital flows globally, and why it matters for sustainable development: In 2024, $368 billion global VC funding has been attributed around the world.[5] For each 100$ given: male-only founding teams captured 84$ while female-only teams received just 2.5$ mixed-gender teams 14$ female-led startups generally receive less than half the average deal size of male-led startups ($5.2 million vs. $11.7 million) The funding disparity also intensifies as startups scale, with female-only teams securing only 1.8% of Series C+ funding.[6] This gap widens further for intersectional women founders. For women who are also Black, Latina, or from other minority groups, getting money becomes even harder. They face double the challenges; people doubt them because they're women AND because of their race or background. The venture capital data reveals the scope of the problem: Female founders  received only 1.9% of all VC funding globally in 2022 Black entrepreneurs  received less than 1% of all VC funding in 2022, despite representing 13% of the U.S. population Latina entrepreneurs  received just 0.43% of VC funding between 2009-2020 LGBTQ+ founders  received approximately 1% of VC funding in recent years.[7]   The situation gets so desperate that some women have actually pretended to have (white) male business partners or even invented fake (white) male bosses just to get investors to take them seriously. A striking example of gender bias in entrepreneurship comes from the founders of Witchsy, an online art marketplace. Penelope Gazin and Kate Dwyer, frustrated by repeated condescension and dismissive attitudes from developers and potential partners, invented a fictional male co-founder named "Keith Mann." The difference was immediate and stark: while Penelope Gazin and  Kate Dwyer often struggled to get timely responses or were addressed patronizingly ("Okay, girls..."), emails from "Keith" were met with prompt replies, respect, and offers of additional help. As Kate Dwyer described, "It was like night and day." The mere presence of a male persona led to their business being taken more seriously, exposing just how deeply ingrained gender bias remains in the startup world, even to the point where a fake male colleague could open doors that were closed to real, capable women.[8] An anecdote known worldwide is the story of a female-led Indian fintech startup where the founder reportedly created a fictional male CEO to overcome investor biases, as male leadership is often perceived as more credible or capable in tech sectors. Meanwhile, Flo Health's  male founders easily raised over $50 million to build their period-tracking app, reaching a billion-dollar value. This isn't just unfair, it's economically inefficient and unsustainable. The health equity connection: when funding gaps become a matter of life and death This funding disparity isn't just about business, it literally affects health outcomes. Medical research funding reveals the same troubling patterns: Women's health research  has been historically underfunded, with conditions affecting primarily women receiving disproportionately less research investment. Endometriosis , affecting 10% of reproductive-age women worldwide, receives only $7 per affected woman in research funding, while erectile dysfunction receives $35 per affected man, despite affecting fewer people overall. Black women's health  faces even starker disparities. Despite having maternal mortality rates 3-4 times higher than white women in the United States, research specifically focused on Black women's health outcomes receives minimal funding. Uterine fibroids . Uterine fibroids disproportionately affect Black women, with data indicating that up to 80% of Black women will develop fibroids by age 50. This prevalence is significantly higher compared to the general population, where fibroids affect a smaller percentage of women overall. Black women not only develop fibroids more frequently but also at an earlier age, and tend to experience larger fibroids with more severe and debilitating symptoms such as pelvic pain, heavy menstrual bleeding, and bladder issues. Despite this high prevalence and severity, uterine fibroids have historically received limited research attention and funding relative to their impact, especially compared to conditions affecting broader populations. For example, the National Institutes of Health (NIH) has only recently begun to increase funding and focus on fibroid research, with legislation such as the Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021 aiming to allocate $30 million annually from 2021 to 2025 to expand research, improve public education, and enhance data collection on affected groups This bill underscores the gap in research and awareness despite fibroids affecting millions of women, including an estimated 26 million Americans with fibroids and about 15 million experiencing severe symptoms. [9] A real-world example illustrating this disparity is the experience of many African American women who often face delayed diagnosis and treatment. Studies show that African American women with fibroids frequently wait four or more years longer than white women to seek treatment, leading to more advanced disease and higher rates of hysterectomy, 2.4 times more often than white women.This further highlights the limited attention this condition has received despite its substantial burden on this population.[10] Sickle cell disease , which predominantly affects people of African descent, receives approximately $286 per patient in research funding, while cystic fibrosis, which primarily affects white populations, receives $3,300 per patient, despite sickle cell disease affecting three times as many Americans.[11] These funding gaps perpetuate health disparities and demonstrate how systemic bias in resource allocation affects the most fundamental aspects of human wellbeing. The parallel between business funding and medical research funding is unmistakable. Both systems consistently undervalue problems primarily affecting women, people of color, and other marginalized communities. This creates a compounding effect where: Communities lack the resources to build solutions for their own problems Research into their specific health needs remains underfunded When solutions do emerge, they're often controlled by outsiders who may not fully understand the community's needs The cycle perpetuates, as successful outsiders become the model for what investors expect. Reframing the problem beyond individual success stories Some argue this is simply about "the best product winning" or that successful outsiders "open doors for others." These arguments miss the fundamental issue: when pattern becomes practice, individual success stories mask systemic failures. The structural barriers are clear: The problem isn't that outsiders ( those who are outside these communities) can't create valuable products for different communities. The problem is that insiders ( people who belong to the communities we seek to serve) face structural barriers that outsiders don't encounter: Access to capital : Women and minority entrepreneurs consistently report difficulty accessing investor networks, particularly problematic when investors can't understand problems they haven't experienced. Credibility assumptions : Research shows investors are more likely to ask women about potential risks and failures, while asking men about potential growth and success, a pattern that systematically disadvantages female entrepreneurs. Network effects : The venture capital world remains overwhelmingly male and white, creating natural advantages for founders who share similar backgrounds with decision-makers. The CSR and sustainability imperative From a corporate sustainability perspective, this represents a massive market failure with far-reaching consequences: Innovation gaps : We're systematically excluding the most knowledgeable voices from solution development Market inefficiency : Capital isn't flowing to the most informed entrepreneurs Social unsustainability : We're perpetuating systems that extract value from communities rather than empowering them Economic instability : Concentrated wealth and opportunity create unsustainable economic structures. Strategic recommendations for sustainable change As CSR and sustainability professionals, we must champion systemic solutions: For investors : Implement diversity metrics and accountability measures. Question why culturally-specific markets lack intersectional leadership. This isn't just ethical, it's risk management. For corporations : Prioritize supplier diversity and authentic community partnerships. Move beyond extractive models toward regenerative business practices that empower rather than exploit. For policymakers : Address structural barriers through targeted programs supporting underrepresented entrepreneurs, particularly in sectors serving their communities. For industry leaders : Recognize that sustainable business models require inclusive leadership. The most sustainable solutions come from those who understand problems through lived experience. The business case for change This isn't charity, it's strategy. Companies that embrace authentic diversity and inclusion in their innovation ecosystems will: Access untapped markets more effectively Develop more sustainable and culturally resonant solutions Reduce reputational risks associated with cultural appropriation Build stronger, more resilient business models The real question This isn't about denying anyone's success or suggesting outsiders can't contribute meaningfully to different markets. It's about recognizing a pattern that demands explanation: Why do those closest to the problems consistently struggle to access the resources needed to build and scale the solutions? Until we address the systemic barriers that create this pattern, we'll continue to see the paradox of outsiders succeeding in markets designed to serve communities they don't represen, while the members of those communities remain locked out of the capital and networks necessary to build their own solutions. The stakes are too high, particularly in health and wellness, to accept this as simply "how markets work." When funding patterns literally affect life and death outcomes, challenging these systems becomes not just about business equity, but about human dignity and survival. The most telling statistic may be this: if the funding disparity were reversed, and women and minority entrepreneurs received 98% of venture capital while white male entrepreneurs received 2%, we would immediately recognize this as a crisis requiring urgent intervention. The fact that the current disparity seems normal reveals just how deeply these biases are embedded in our systems. These examples provoke critical questions: Why do male founders often dominate female-focused or culturally specific markets, even when the products and services primarily serve women or minority communities? How do systemic biases in funding and leadership opportunities exclude women and ethnic minority entrepreneurs from scaling their ventures? What role do cultural norms and investor biases play in shaping who gets to lead and benefit from these markets? How can sponsorship and structural changes in investment ecosystems ensure that women, especially from underrepresented ethnic groups, receive equitable support and recognition? Flo Health’s rise as a male-led femtech unicorn underscores the urgency of these questions. It challenges us to rethink how success is defined and who is given the resources and platforms to lead in sectors deeply tied to identity and lived experience. Without addressing these systemic barriers, culturally specific sectors risk perpetuating exclusion rather than fostering true representation and empowerment. Conclusion The Flo Health phenomenon isn't just about one successful app, it's a mirror reflecting our economic system's fundamental unsustainability. When we consistently exclude those closest to problems from building solutions, we create extractive rather than regenerative business models. True sustainability requires more than reducing carbon footprints; it demands creating economic systems that empower all communities to solve their own challenges while sharing in the value they create. The question isn't whether we can afford to change these systems, it's whether we can afford not to. In an interconnected world facing complex challenges from climate change to health disparities, we need every voice, every perspective, and every innovative solution we can access. The path forward is clear: move from extractive to regenerative business models, from exclusive to inclusive capital allocation, and from systemic barriers to systemic empowerment. This is the true work of sustainable development in the 21st century. As we often say: "Your problem may not be sustainability per se, but the solution is." The funding disparity crisis is no exception, and the sustainable solution lies in building economic systems that recognize and reward the expertise of those closest to the challenges we face. [1] https://techcrunch.com/2024/07/30/fertility-tracking-app-flo-health-raises-200m-at-a-1b-valuation/ [2] https://www.sarah-archer.com/writing/2017/2/13/test-article-2 [3] https://journals.library.columbia.edu/index.php/lawandarts/announcement/view/42 [4] https://qz.com/africa/2012137/adidass-xhosa-inspired-shoes-werent-released-in-south-africa [5] https://kpmg.com/xx/en/media/press-releases/2025/01/2024-global-vc-investment-rises-to-368-billion-dollars.html [6] https://ff.co/women-funding-statistics-2025/ [7] https://pitchbook.com/ 8 [8] https://www.weforum.org/stories/2017/09/these-female-entrepreneurs-invented-a-fake-male-co-founder-for-their-business/ [9] https://www.congress.gov/bill/117th-congress/house-bill/2007 [10] https://www.scientificarchives.com/article/racial-disparities-in-surgical-outcomes-for-uterine-fibroids-a-systematic-review [11] https://www.thinkglobalhealth.org/article/lifelong-struggle-sickle-cell-disease#:~:text=Further%20evidence%20of%20systemic%20racism%20is%20exemplified,for%20this%20disease%20compared%20to%20cystic%20fibrosis

Octobre Rose If women's health challenges were a video game, we'd be stuck on the level that keeps adding new villains faster than we can defeat the old ones. Everything , Everywhere, All at once First, the medical world used men as the “default” research subject because women’s bodies were “too complex” (translation: inconvenient). Then we learned heart attacks look different in women, but no one told the ER. And now? Climate change add to the party has beeing the newest cancer risk factor. Because why should women only worry about tobacco, alcohol, HPV, genetics, workplace toxins, and societal pressure? The study that should make us all sweat (And not just from hot flashes) According to a groundbreaking study from the American University in Cairo, for every 1°C increase in temperature, cancer cases in women rise by 173–280 per 100,000 people. Let me put that in perspective. Imagine if every time your house got one degree warmer, your risk of a burglar breaking in increased by hundreds of percent. You'd probably invest in some serious air conditioning, right? But we're not talking about your thermostat. We're talking about the entire planet's thermostat. And unlike your home AC, there's no quick fix button. The researchers studied 17 countries in the Middle East and North Africa, a region expected to warm by 4°C by 2050—and found that breast, ovarian, uterine, and cervical cancers all became more common AND more deadly with each degree of rising temperature. This isn't about better detection, either. Deaths went up too. [1] Climate change: The toxic ex-partner that just won’t leave women alone You know that ex who shows up uninvited, ruins your peace, and won’t take a hint? That’s climate change for women’s health. Here's how this toxic relationship works: 1. The direct hits Rising temperatures mean more UV radiation (ozone depletion), more air pollution from droughts and wildfires, and more exposure to environmental carcinogens. Yes, these affect everyone, but here's where it gets specifically worse for women: Women are physiologically more vulnerable to climate-related health risks, particularly during pregnancy. And women face more barriers getting screened and treated (remember that 12.7% gender pay gap and the fact that women provide 2/3 of all caregiving?). So the same environmental exposure + worse access to healthcare = worse outcomes for women.[2] It's like if two people got caught in the same storm, but one person has a raincoat and an umbrella while the other has neither AND is carrying a baby. Two people got caught in the same storm... 2. The biological betrayal Higher temperatures can literally mess with your cells, causing oxidative stress, DNA damage, and inflammation. Heat stress can disrupt hormones in breast and ovarian tissue. Your body is basically trying to survive in a hostile environment, and cancer cells are taking advantage of the chaos.[2] 3. The healthcare breakdown Extreme weather doesn't just make you uncomfortable, it disrupts healthcare systems, making it harder for women to get screened, diagnosed, and treated early when cancer is most beatable. Think of it like this: Climate change is like a villain that attacks on three fronts simultaneously: your body, your environment, and your ability to get help. No wonder cancer rates are going up. And just like everything else, It emphasises systemic inequalities Here’s where CSR strategists like us stop being polite and start being real. Marginalized women face a multiplied risk because they are more exposed to environmental hazards and less able to access early screening and treatment services Dr. Sungsoo Chun explains.[1] In plain English? Climate change is hitting the women least equipped to fight back, the hardest. If you're poor, living in a rural area, or belong to a marginalized community, climate change is coming for you harder than anyone else. It's like climate change looked at all the existing inequalities women face and said, "You know what? Let's make ALL of this worse." If you're poor, living in a rural area, or belong to a marginalized community, climate change is coming for you harder than anyone else. It's like climate change looked at all the existing inequalities women face and said, "You know what? Let's make ALL of this worse." According to a report written by the European Cancer Organisation [3], 12 million women in Europe are living with cancer right now? The report details what women face right now: Gender-based marketing from tobacco and alcohol industries Lower screening rates in vulnerable communities Financial toxicity (because treatment is expensive and women earn less) Caregiving burdens (women provide 2/3 of all informal care) Workplace discrimination after diagnosis Underrepresentation in clinical trials Now add "surviving a heating planet" to that list. What should make you angry Ovarian cancer cases rose the MOST with temperature increases Breast cancer cases rose the least (but still rose) Deaths increased by 171 to 332 per 100,000 people for each degree rise The biggest increases happened in Qatar, Bahrain, Jordan, Saudi Arabia, UAE, and Syria At this rate, a 4°C rise means quadruple the cancer impact in some regions by 2050. Do the math.   That's potentially four times the current increase in cancer cases and deaths. In a region where 420,812 people already died from cancer in 2019, with 175,707 being women. Now let's talk about Europe. Europe is warming too. Not as fast as the Middle East (yet), but it's warming. Europe currently has 12 million women living with cancer. Climate change could add almost 800,000 more to that number by 2050, and that's with a conservative 2°C warming scenario. If Europe warms by 3-4°C (which some models predict for Southern Europe), those numbers double or triple. And remember: Europe isn't starting from zero Unlike the Middle East, Europe already has: 1.2 million new cancer diagnoses in women every year 600,000 women dying from cancer annually Massive inequalities in screening access (remember: only 7 EU countries offer cervical self-sampling) Climate change isn't creating a new problem. It's pouring gasoline on a fire that's already burning. What makes this different from every other cancer risk we know? You can quit smoking.  You can limit alcohol. You can get the HPV vaccine. You can use sunscreen. But you can't opt out of the planet's temperature. It's like if someone told you breathing increased your cancer risk. What are you supposed to do? Stop breathing? Climate change is what experts call a "systemic risk", it touches EVERYTHING. And unlike other risk factors that individuals can modify, this one requires massive, coordinated global action. The triple threat: Biology, environment & access Dr. Sungsoo Chun summarized it perfectly: “Temperature rise acts through multiple pathways, exposure to carcinogens, healthcare disruption, and cellular stress, compounding women’s cancer risk over time.” In CSR terms, that’s interconnected system failure. Biological: Your cells are under stress from heat, inflammation is up, hormones are disrupted, even HPV (the virus that causes cervical cancer) might behave differently in hotter conditions. Environmental: More wildfires = more air pollution. More droughts = contaminated water. More heat = more time outdoors getting UV exposure. More extreme weather = destroyed infrastructure. Access: When hospitals are dealing with heat emergencies, cancer screenings get postponed. When roads are flooded, you can't get to treatment. When you're spending all your money on cooling your home, you can't afford healthcare. The cruel irony: Women are part of the solution but bear the burden Here's what really gets us: Women are disproportionately affected  by climate change's health impacts. But women also: Make up 70% of the health and care workforce (dealing with the fallout) Provide 2/3 of all informal caregiving (taking care of sick family members) Are more likely to adopt sustainable behaviors (trying to fix the problem) Face more barriers in healthcare systems (making prevention and treatment harder) It's like being forced to clean up a mess you didn't make while someone keeps dumping more garbage on your head. What needs to happen Climate action Real emissions cuts (no, “net-zero by 2070” doesn’t count) Investment in climate-resilient healthcare Recognition that climate justice IS health justice IS gender justice Health equity Free, accessible cancer screening f or ALL women Research that includes sex and climate variables Research funding that includes women AND climate impacts Training healthcare providers to understand these intersecting risks Health systems that can withstand floods, fires, and heatwaves Corporate Responsibility Stop gendered marketing of cancer-causing products (yes, tobacco and alcohol industries, I'm looking at you with your "pink gin" and "Mommy wine") Address the gender pay gap (12.7% in the EU) so women can afford healthcare Support for caregivers (who are mostly women) Recognition that marginalized women face compounded risks Women aren’t a research variable, they’re half the population We’re conducting a real-time global experiment on women’s bodies, without consent. Underrepresentation in clinical trials? Check. Gender bias in diagnosis? Check. Underfunding in women’s cancers? Check. And now, add a planetary temperature variable nobody can escape. This isn’t science, it’s negligence on a planetary scale. What You Can Actually Do Personally: Get screened regularly. Understand your environmental risk factors. Support orgs linking climate justice + women’s health. Vote like public health depends on it (because it does). Collectively: Demand climate-health integration in all CSR strategies. Support universal screening access. Expose greenwashing and pink-washing. Policy-wise: Mandate climate-risk analysis in public health planning. Fund research on gendered climate impacts. Recognize healthcare as part of climate adaptation. What success looks like A world where: Health systems are climate-resilient Women’s cancers are prioritized and preventable Climate policy is gender-smart Corporate responsibility includes health outcomes That’s not utopian. That’s good governance, and smart CSR. Climate change is not just an environmental issue. It’s a women’s health crisis. Cancer is not just a disease. It’s a symptom of systemic inequality. We can still rewrite this story, but only if we stop treating climate, health, and gender as separate conversations. Because when the planet burns, women’s bodies bear the scars. [1] https://www.frontiersin.org/news/2025/05/27/global-warming-could-be-driving-womens-cancer-risk-frontiers-public-health [2] https://www.washingtonpost.com/climate-environment/2025/05/27/climate-change-heat-cancer-women [3] https://www.europeancancer.org

How three pioneering scientists uncovered the secret behind autoimmune diseases, and what it means for our future. Our immune system is one of the most sophisticated defense mechanisms ever evolved. It’s like a highly trained security team, constantly on alert for threats like bacteria, viruses, or even cancer. But what happens when that security team goes rogue and starts attacking the very people it’s meant to protect? That’s the question scientists have been struggling with for years. And this week, the Nobel Prize in Medicine provided an answer that could change the way we understand diseases like autoimmune disorders , conditions where the immune system mistakenly attacks the body’s own tissues. The 2025 Nobel Prize in Medicine was awarded to Shimon Sakaguchi , Mary E. Brunkow , and Fred Ramsdell  for their groundbreaking discovery of how the immune system prevents this from happening, which also has profound implications for the future of medicine and even our planet’s health.[1] Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi won the Nobel Prize in medicine 2025 The scientist who proved everyone wrong In 1995, the scientific accepted knowledge was that the immune system learned tolerance through a simple process: Any immune cell that wanted to attack "you" got eliminated in the thymus (an organ behind your breastbone) during development. Done. Problem solved. This was called central tolerance , and everyone was pretty comfortable with this explanation. Sakaguchi looked at this and though that can't be the whole story. And he was right. He discovered the immune system has its own security team, regulatory T cells. They ensure the body’s defense forces don’t turn on themselves. These “bouncers” patrol your body, keeping the immune system in check. Without them, your immune system would behave like a wild vigilante, attacking anything that looks suspicious, even your own organs. T cells Think of it this way: The old theory said your body just doesn't hire  security guards who might shoot the guests. Sakaguchi proved that your body actually does  hire those guards, but then assigns other  guards to follow them around and tackle them if they get trigger-happy. It's surveillance on your surveillance. It's what is called the immune system inception. So, what happens when these regulatory cells fail? Without functional regulatory T cells, your immune system becomes a vigilante with no supervision, attacking anything that looks suspicious, including your own organs. Diseases like rheumatoid arthritis , type 1 diabetes , and multiple sclerosis  are all examples of autoimmune conditions where the immune system mistakenly targets its own tissues, causing inflammation and damage. One of the most severe forms of this is Systemic Lupus Erythematosus, a disease where the immune system attacks everything from joints to skin to organs like the heart and kidneys. Widespread lupus patches across the face A key breakthrough This year’s Nobel Prize-winning research centers around the discovery of regulatory T cells  and their vital role in preventing this type of self-destruction. Mary Brunkow and Fred Ramsdell were studying mice that kept developing terrible autoimmune diseases. These mice were basically allergic to themselves. They found the culprit: a mutated gene they named Foxp3 . FOXP3 Gene When this gene doesn't work, regulatory T cells don't develop properly. And when that happens? Total chaos happens. The immune system attacks everything. It turns against the body, leading to autoimmune disorders. The implications of this are huge. By understanding how to enhance or restore the function of these regulatory cells, scientists are developing potential therapies for autoimmune diseases. For example, in diseases like type 1 diabetes , where the immune system attacks insulin-producing cells in the pancreas, this discovery could eventually lead to treatments that restore balance and prevent this self-destructive behavior. They also discovered that humans with mutations in this gene develop IPEX , a devastating autoimmune disease that can affect multiple organs. Imagine a city where all the police officers quit. That's what happens when Foxp3 doesn't work. Your immune system becomes a riot. The connection that won the Nobel In 2003, Sakaguchi connected the dots. He proved that the Foxp3 gene is the master control switch  for regulatory T cells. It's what tells these cells to develop and do their job. This was the breakthrough. what it quite rightly identifies asSuddenly, scientists understood: What  keeps the immune system in check (regulatory T cells) How  these cells develop (the Foxp3 gene) Why  some people develop autoimmune diseases (Foxp3 mutations) It's like finding not just the murder weapon, but also the killer and  their motive. Why should you care? (Besides the whole "Not dying" thing) Here's where this gets really exciting, and why this isn't just purely academic exercise. Understanding regulatory T cells has launched an entire field of medicine . We're talking: Cancer treatments  that remove the brakes from your immune system so it can attack tumors Autoimmune disease therapies  that strengthen the regulatory T cells to calm down overactive immunity Better organ transplants  by teaching the immune system to tolerate what it quite rightly identifies as foreign tissue Multiple treatments currently in clinical trials The conventional wisdom in medicine used to be: suppress the entire immune system (steroids) or boost the entire immune system (early immunotherapy). This discovery showed us we can target specific parts of the immune system. We can boost the parts we need and calm down the parts causing problems. The truth about scientific breakthroughs Here's what strikes us as a CSR strategist: 2025's Nobel Prizes tell the same story three times over. Medicine:  Sakaguchi discovered regulatory T cells in 1995. The scientific community told him he was wrong. Everyone "knew" that immune tolerance happened only in the thymus. Brunkow and Ramsdell found the Foxp3 gene in 2001. Sakaguchi connected them in 2003. Nobel Prize: 2025.   Gap: 22-30 years. Chemistry:  Richard Robson started drilling holes in wooden balls for a chemistry lesson in 1974,  sparking an idea about molecular frameworks. Susumu Kitagawa presented his first molecular construction in 1992. It wasn't particularly useful at first. Omar Yaghi developed stable metal-organic frameworks in the late 1990s. Nobel Prize: 2025.   Gap: 33-51 years. Physics:  John Clarke, Michel Devoret, and John Martinis demonstrated macroscopic quantum tunneling in superconducting circuits in 1984-1985. Clarke said The idea it might win a Nobel "had never occurred to me. Nobel Prize: 2025.   Gap: 40-41 years. All three discoveries challenged conventional wisdom. All three were dismissed, doubted, or deemed "useless" initially. All three persisted anyway. And all three took decades  to receive recognition, even though they fundamentally changed their fields and are now saving lives, cleaning water, and powering quantum computers. What this means for healthcare, pharma, and climate investment If your company has any stake in R&D, whether healthcare, materials science, climate tech, or advanced computing, this should tell you something critical: The breakthroughs that challenge conventional wisdom are exactly the ones worth betting on. Kitagawa followed a principle he learned from Nobel laureate Hideki Yukawa: to see "the usefulness of useless." When funders rejected his work because it "had no purpose," he kept going. Now MOFs harvest water from deserts and capture carbon from the atmosphere. The entire field of immune checkpoint inhibitors , cancer drugs that won the 2018 Nobel Prize[2] and generate billions in revenue, builds directly on understanding regulatory T cells. The foundation was laid in 1995. Recognition came 30 years later. We're really bad at recognizing breakthrough innovations when they're happening. The 2025 Nobel Prizes in Medicine, Chemistry, and Physics all honored work that's 22-51 years old. Not because the science took that long to matter, after all, these discoveries have been transforming their fields for decades; but because it takes that long for the world to fully grasp just how wrong we were before. The moral? The most important discoveries are often the ones that make everyone else say "wait, that can't be right" at first. Beyond the lab: How this links to climate change Climate change, much like autoimmune diseases, is a global system failure. In the same way that the immune system, when unbalanced, turns against the body, the environment, when disrupted by human activity, begins to fight back. Extreme weather events, rising sea levels, and global health crises like heat strokes or the spread of infectious diseases are the symptoms of a much larger, systemic breakdown. Just as scientists are now focusing on restoring balance to the immune system by enhancing regulatory T cells, we need to do the same for the planet. The groundbreaking work of the Nobel Prize winners shows that complex systems, whether biological or environmental, thrive when they maintain checks and balances. But when those systems are out of control, the consequences are tremendous. What can businesses do? Adopt a systems thinking approach : Just as regulatory T cells balance the immune system, businesses can adopt a holistic, systems-based approach to sustainability. This means understanding the interconnections between climate change, biodiversity, and social welfare. It’s about recognizing that disrupting one part of the system can have ripple effects across the entire global ecosystem, much like how a malfunctioning immune system leads to autoimmune diseases. Invest in climate solutions : By supporting scientific advancements that aim to restore ecological balance (whether through clean energy, carbon capture, or reforestation), businesses can help “calm” the environmental immune system, just as new treatments are being developed for autoimmune diseases. Corporate Social Responsibility (CSR) and the future of health : The same principle of balance applies in CSR initiatives, companies that focus on responsible environmental practices, social equity, and ethical governance are contributing to a healthier global ecosystem. Supporting clean tech, sustainable supply chains, and renewable energy projects not only combats climate change but also supports human health by reducing air pollution, water scarcity, and the spread of diseases. Nobel prize medal [1] https://www.nobelprize.org/prizes/medicine/2025/press-release/ [2] https://www.nobelprize.org/prizes/medicine/2018/press-release/